Our Latest Webinar: "Understanding Autoimmune CAR-T Therapy"

Autoimmune diseases affect approximately 10% of the global population. Although treatments are available to control immune responses and manage symptoms, these diseases generally remain incurable. However, the rapid clinical adoption of breakthrough CAR-T technology holds the promise of drug-free remission for patients with severe autoimmune conditions, such as systemic lupus erythematosus (SLE), myositis, and systemic sclerosis.

In this webinar, Dr. Allan Zhang provided an overview of the current status of autoimmune CAR-T therapy. Key topics included:

- The typical process of CAR-T therapy

- The rationale for using CAR-T in autoimmune diseases

- The swift clinical application of CAR-T in treating these conditions

- Potential mechanisms of action

- Novel CAR-T technologies for autoimmune diseases

- The challenges and opportunities in this emerging field

To watch the recorded webinar in its entirety, please click the link.

How T&L Biotechnology Can Support You in the Field of Cell & Gene Therapy (CGT)

At T&L Biotechnology, we are dedicated to supporting researchers at the forefront of CGT, including those working on CAR-T technology for autoimmune diseases. We offer a comprehensive range of GMP-grade products, such as magnetic cell sorting beads, recombinant proteins, and cryopreservation solutions, tailored for cutting-edge research and clinical applications. Our extensive experience and robust portfolio are designed to simplify your workflows and drive innovation in CGT.

If you are interested in scheduling a meeting to discuss how our products and services can meet your needs, please click the link to view our calendar and find a suitable time for a conversation.